WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Website Related Website Development Sunday, May 10, 2026 
Add Press Release News | News Feeds Feeds | Email This News Email


Global Therapeutic Biological Drugs Market Report 2022: Economics, Technologies, Disease Segments, and Commercial Opportunities
Thursday, February 3, 2022

DUBLIN, Jan. 26, 2022 /PRNewswire/ -- The "Therapeutic Biologics to 2026" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Therapeutic Biologicals to 2026 is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector.

The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for therapeutic biological drugs. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Engineered Therapeutics for Refractory Conditions

Led by the proliferation of antibody-based drugs and candidates, biological drugs as a class continue to outpace all other NCEs in development pipelines and clinical trials.

This shift away from small molecule drugs is creating opportunities for drug developers, device designers, packagers and ultimately pharmaceutical marketers. Because biological drugs most often target chronic conditions, dosing strategies and treatment protocols must be developed for long-term use, often for self-administration by patients who may have limitations directly related to their condition.

The shift in supplied packaging from single and multi-use vials to prefilled injection devices will accelerate over the next five years as drug developers move to empower an increasing number of chronically ill patients. The powerful physiological effects of antibodies, hormones and other biological drugs also increase the need for safety and compliance.

What You Will Learn

    --  What are the market factors that define the therapeutic biologicals
        market?
    --  What are the major factors driving product development strategies within
        biologicals drug development organizations?
    --  How does the availability of patient support resources influence
        prescribing decisions for biological drugs?
    --  How important are drug developer-formulation technologist relationships
        in therapeutic market segments?
    --  What is the current state of the global biologicals development and
        manufacturing ecosystem?
    --  What are the significant economic, technology, and regulatory factors
        affecting the selection criteria for therapeutic biological drugs?

Key Topics Covered:

Biological Drug Product Factors

    --  As-supplied Packaging
    --  Formulation Factors
    --  Biological Drug Delivery Ecosystem
    --  Technology Factors

Competitive Landscape

Global Biologics Supply Ecosystem

    --  North America
    --  Europe
    --  Asia

Therapeutic Biologicals - Patient Prescribing Segments

    --  Point of Care
    --  Self-administration

Market Presence of Leading Biologicals Suppliers

Drug Class Market Analysis

    --  Enzymes
    --  Fusion Proteins
    --  Granulocyte - Colony Stimulating Factor (G-CSF)
    --  Hormones
    --  Immune Modulators
    --  mAbs
    --  Recombinant Proteins

Biological Drug Profiles

Market Data and Forecasts

Delivery Devices & Suppliers for Biological Drugs

For more information about this report visit https://www.researchandmarkets.com/r/y5raqr

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

View original content:https://www.prnewswire.com/news-releases/global-therapeutic-biological-drugs-market-report-2022-economics-technologies-disease-segments-and-commercial-opportunities-301468584.html

SOURCE Research and Markets



Email This News Email | Submit To Slashdot Slashdot | Submit To Digg.com Digg | Submit To del.icio.us Del.icio.us | News Feeds Feeds

RELATED NEWS ARTICLES
Nav Asetek - Mandatory Notification of Trade | Jan 22, 2026
Nav BC.GAME to Host "Stay Untamed" Night During Abu Dhabi's Packed Web3 Summit Week | Jan 22, 2026
Nav Tomorrowland Brings the Magic to Shanghai for a Spectacular First Indoor Edition in China | Jan 22, 2026
Nav Rent Manager Earned Best Real Estate Software Product Award and Multiple Review Badges from G2 Platform | Jan 22, 2026
Nav Auburn University's Applied Research Institute Expands Advanced Manufacturing Capabilities with CF3D Enterprise Cell | Jan 22, 2026
Nav California Divorce Mediation Center Unveils Modern Website Redesign | Jan 22, 2026
Nav AMPERA ANNOUNCES LOCATION FOR GLOBAL HEADQUARTERS | Jan 22, 2026
Nav Gemmy Alerts Customers: Fake Websites Target Holiday Decorators | Jan 22, 2026
Nav AMPLIFY Named Finalist in Three Categories at the 2026 Golden Gavel Awards | Jan 22, 2026
Nav Culture and tourism sectors thrive in Xiamen | Jan 22, 2026
NEWS SEARCH

FEATURED NEWS | POPULAR NEWS
Submit News | View More News View More News